JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laffineur, K.
Right arrow Articles by Delmée, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laffineur, K.
Right arrow Articles by Delmée, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2002, p. 1085-1087, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1085-1087.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Biochemical and Susceptibility Tests Useful for Identification of Nonfermenting Gram-Negative Rods

Kim Laffineur, Michèle Janssens, Jacqueline Charlier, Véronique Avesani, Georges Wauters,* and Michel Delmée

Microbiology Unit, Faculty of Medicine, University of Louvain, B-1200 Brussels, Belgium

Received 21 June 2001/ Returned for modification 23 October 2001/ Accepted 10 December 2001


   ABSTRACT
Top
 Abstract
Text
 References
 
Six hundred nineteen strains of nonfermenting gram-negative rods were tested for alkaline phosphatase, benzyl-arginine arylamidase, pyrrolidonyl arylamidase, ethylene glycol acidification, and susceptibility to desferrioxamine and colistin. The results were highly discriminant. Therefore, the proposed tests may be helpful for the identification of this group of organisms.


   TEXT
Top
 Abstract
 Text
References
 
Identification of gram-negative nonfermenting rods by conventional methods is often difficult and time-consuming, and commercial systems do not always provide reliable identification, especially of some genera or species (7, 17, 19). Moreover, recent taxonomic studies resulted in the description of an increasing number of new genera and species involved in nosocomial infections and requiring additional tests for identification. This was true, for instance, for the new genus Ralstonia (2, 3, 14), the former "Flavobacterium" group (12, 13), and others. In this study, we investigated a large number of strains for six biochemical and susceptibility characteristics that are rarely or not at all included in conventional schemes. Alkaline phosphatase (PHO), benzyl-arginine arylamidase (BAA), and pyrrolidonyl arylamidase (PYR), three enzymatic tests, are sometimes included in commercial systems, but they are not systematically reported in existing identification schemes (4, 6, 11). Susceptibility to desferrioxamine has been proposed for the identification of coagulase-negative staphylococci (9) but not for gram-negative bacilli. Acid production from ethylene glycol was described in corynebacteria (20) but, as far as we know, has not been evaluated in nonfermenters. We have also included susceptibility to colistin, although susceptibility to polymyxin B is often mentioned in conventional schemes (4, 6, 11), but low colistin content disks may yield slightly different results.

Five hundred fifty-three clinical isolates of nonfermenting gram-negative rods and 66 reference strains, including type strains, were tested. They included 41 species or Centers for Disease Control and Prevention (CDC) groups (Table 1). Only fast growers on tryptic soy agar were investigated. Moraxella spp. and other fastidious nonfermenters were excluded, as were Acinetobacter spp. because the latter can be identified on the basis of a few simple routine tests. All tests and cultures were performed at 30°C. For enzymatic reactions, diagnostic tablets from ROSCO (Taastrup, Denmark) were used in accordance with the manufacturer's instructions with slight modifications. Tablets were put in 0.5 ml of a 3 to 4 McFarland bacterial suspension and incubated for 4 h. Reading of BAA and PYR was done after addition of 1 drop of cinnamaldehyde reagent. PHO turned yellow when positive; no color or a pale yellowish color was considered negative. Determination of acid production from ethylene glycol was performed as previously described (20). Susceptibility to desferrioxamine was determined on Mueller-Hinton agar using 6-mm-diameter paper disks loaded with 250 µg of desferrioxamine (9). Testing for susceptibility to colistin was also carried out on Mueller-Hinton agar using commercial paper disks containing 10 µg of colistin (Becton Dickinson, Cockeysville, Md.). Strains displaying any inhibition of growth were recorded as susceptible. Conventional identification of the strains was performed in accordance with existing schemes (4, 6, 11), including flagellar staining for the vast majority of motile strains and cellular fatty acid analysis where appropriate. Strains showing an unusual profile or one or more atypical characteristics by conventional tests were submitted to 16S rRNA gene sequencing in order to rule out or confirm questionable identifications (8).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Percentages of positive results obtained with the six proposed testsa

 
Results of the six proposed tests are reported in Table 1. Most of the tests yielded a large number of 100% or 0% positivity rates, resulting in a high discriminant value. However, 13 taxa contained fewer than 10 strains, which does not allow a statistically significant assessment of the results. Nevertheless, if only the 28 species or taxa represented by more than 10 strains are taken into account, tests like BAA achieved a 100% or 0% score for 93% (26 out of 28) of them. The values for the other tests were higher than 80%, except for ethylene glycol, which was only 54%. When considering more than 90% and less than 10% positivity rates as positive and negative results, respectively, a unique profile for the six tests was exhibited by five species: Burkholderia cepacia, Burkholderia pseudomallei, Ralstonia pickettii, Comamonas terrigena genomovar 1, and Weeksella virosa. Several other profiles were shared by only two taxa. Although these profiles do not constitute an identification system by themselves, they may provide a prominent contribution to a correct identification.

Colistin (polymyxin E) and polymyxin B have similar activities, and the interpretive diameters of resistance and susceptibility for therapeutic purposes are approximately the same when 10-µg colistin disks and 300-U polymyxin B disks are used (1). In this study, however, the results obtained for some species with the 10-µg colistin disks for diagnostic purposes sometimes differed from those reported for polymyxin B. Many Agrobacterium radiobacter strains were resistant and displayed full growth at the edge of the disk, whereas they have been reported to be susceptible to polymyxin B (11). Ochrobactrum anthropi strains were susceptible overall, but results for some strains were difficult to interpret because there was only partial inhibition around the disk. As expected, the type strain of O. intermedium was clearly resistant, as was one clinical isolate confirmed as O. intermedium by 16S gene sequencing (18). All Delftia (formerly Comamonas) acidovorans isolates were uniformly resistant, while the related species Comamonas testosteroni and C. terrigena were susceptible.

Some tests or combinations of tests allowed us to rule out some genera or species, or they were highly suggestive for a group of organisms. For example, BAA activity and susceptibility to colistin are always present in Pseudomonas species but never in Burkholderia spp. or in Ralstonia pickettii or Ralstonia mannitolytica. BAA activity with a strong PHO reaction, resistance to colistin, and susceptibility to desferrioxamine in motile nonfermenters are almost always specific to Brevundimonas spp. The three enzymatic reactions PHO, BAA, and PYR are, as a rule, positive in members of the former "Flavobacterium" group, including Chryseobacterium, Empedobacter, Myroides, and Sphingobacterium spp. Among the two Myroides species (12), Myroides odoratimimus is more frequently isolated in humans than is M. odoratus. In our series, only one clinical isolate was identified as M. odoratus by cellular fatty acid analysis and 16S gene sequencing. It is noteworthy that only this isolate and the type strain of M. odoratus were susceptible to desferrioxamine, in contrast to M. odoratimimus strains, but this should be confirmed in the future with a larger number of strains. Susceptibility to desferrioxamine allows us to distinguish easily between Comamonas terrigena and Comamonas testosteroni. Moreover, among the three genomovars of Comamonas terrigena outlined by Willems et al. (21), genomovar 1 is positive for PYR activity but genomovars 2 and 3 are negative.

Correct identification of Burkholderia cepacia is often considered difficult (5, 7, 17). This species is of prominent importance in cystic fibrosis patients. Recent studies have proved the heterogeneity of the species both genomically and phenotypically, and several new species have been proposed within the former group (5, 15, 16). Phenotypic profiles may be confused with those of similar species. In this respect, all of our strains failed to exhibit the two enzymatic activities BAA and PYR, and although the number of strains was limited, this might be helpful in distinguishing the Burkholderia cepacia complex from Burkholderia gladioli (results not shown), Ralstonia pickettii, and Ralstonia mannitolytica, which are all PYR positive.

Kiska et al. evaluated four different commercial systems for the identification of Burkholderia cepacia and other nonfermenting gram-negative bacilli recovered from patients with cystic fibrosis: RapID NF Plus (Innovative Diagnostic Systems, Norcross, Ga.), API Rapid NFT (bioMérieux-Vitek, Hazelwood, Mo.), Vitek Auto/Microbic System GNI (bioMérieux-Vitek), and Uni-N/F Screen (Remel, Lenexa, Kans.). They reported results ranging from 43 to 86% for Burkholderia cepacia and from 57 to 80% for all nonfermenters (7). Furthermore, in a study of the Crystal Enteric/Non-Fermenter system (Becton Dickinson), only 75% of the nonfermenters were correctly identified and a similar identification score was achieved by the API 20NE system (bioMérieux, Marcy l'Etoile, France) (19). Hence, commercial identification systems do not always provide satisfactory results for the identification of gram-negative nonfermenting rods.

The tests proposed in this study may improve the identification of gram-negative nonfermenting rods either by their inclusion in conventional schemes or as complementary tests when results obtained by other methods are ambiguous or questionable.


   ACKNOWLEDGMENTS
 
We are grateful to M. Vaneechoutte for providing us with several strains.


   FOOTNOTES
 
* Corresponding author. Mailing address: University of Louvain, Microbiology Unit, UCL/5490, Av. Hippocrate 54, B-1200 Brussels, Belgium. Phone: 32(0) 2 7645490. Fax: 32(0) 2 7649440. E-mail: wauters{at}mblg.ucl.ac.be. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Bauer, A. W., W. M. M. Kirby, J. C. Sherris, and M. Turck. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.[Medline]
  2. Coenye, T., E. Falsen, M. Vancanneyt, B. Hoste, J. R. W. Govan, K. Kersters, and P. Vandamme. 1999. Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int. J. Syst. Bacteriol. 49:405-413.[Abstract/Free Full Text]
  3. De Baere, T., S. Steyaert, G. Wauters, P. De Vos, J. Goris, T. Coenye, T. Suyama, G. Verschraegen, and M. Vaneechoutte. 2001. Classification of Ralstonia pickettii biovar 3/‘thomasii’ strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int. J. Syst. Evol. Microbiol. 51:547-558.[Abstract]
  4. Gilligan, P. H., and S. Whittier. 1999. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, and Acidovorax, p. 526-538. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
  5. Henry, D. A., E. Mahenthiralingam, P. Vandamme, T. Coenye, and D. P. Speert. 2001. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 39:1073-1078.[Abstract/Free Full Text]
  6. Kiska, D. L., and P. H. Gilligan. 1999. Pseudomonas, p. 517-525. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
  7. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.[Abstract]
  8. Kolbert, C. P., and D. H. Persing. 1999. Ribosomal DNA sequencing as a tool for identification of bacterial pathogens. Curr. Opin. Microbiol. 2:299-305.[CrossRef][Medline]
  9. Lindsay, J. A., and T. V. Riley. 1991. Susceptibility to desferrioxamine: a new test for the identification of Staphylococcus epidermidis. J. Med. Microbiol. 35:45-48.[Abstract]
  10. Moss, C. W., P. L. Wallace, D. G. Hollis, and R. E. Weaver. 1988. Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis. J. Clin. Microbiol. 26:484-492.[Abstract/Free Full Text]
  11. Schreckenberger, P. C., and A. von Graevenitz. 1999. Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods, p. 539-560. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
  12. Vancanneyt, M., P. Segers, U. Torck, B. Hoste, J. F. Bernardet, P. Vandamme, and K. Kersters. 1996. Reclassification of Flavobacterium odoratum (Stutzer 1929) strains to a new genus, Myroides, as Myroides odoratus comb. nov. and Myroides odoratimimus sp. nov. Int. J. Syst. Bacteriol. 46:926-932.[Abstract/Free Full Text]
  13. Vandamme, P., J.-F. Bernardet, P. Segers, K. Kersters, and B. Holmes. 1994. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int. J. Syst. Bacteriol. 44:827-831.[Abstract/Free Full Text]
  14. Vandamme, P., J. Goris, T. Coenye, B. Hoste, D. Janssens, K. Kersters, P. De Vos, and E. Falsen. 1999. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int. J. Syst. Bacteriol. 49:663-669.[Abstract/Free Full Text]
  15. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. W. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.[Abstract/Free Full Text]
  16. Vandamme, P., E. Mahenthiralingam, B. Holmes, T. Coenye, B. Hoste, P. De Vos, D. Henry, and D. P. Speert. 2000. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J. Clin. Microbiol. 38:1042-1047.[Abstract/Free Full Text]
  17. Van Pelt, C., C. M. Verduin, W. H. F. Goessens, M. C. Vos, B. Tümmler, C. Segonds, F. Reubsaet, H. Verbrugh, and A. van Belkum. 1999. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J. Clin. Microbiol. 37:2158-2164.[Abstract/Free Full Text]
  18. Velasco, J., C. Romero, I. Lopez-Goni, J. Leiva, R. Diaz, and I. Moriyon. 1998. Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. Int. J. Syst. Bacteriol. 48:759-768.[Abstract/Free Full Text]
  19. Wauters, G., A. Boel, G. P. Voorn, J. Verhaegen, F. Meunier, M. Janssens, and L. Verbist. 1995. Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J. Clin. Microbiol. 33:845-849.[Abstract]
  20. Wauters, G., B. Van Bosterhaut, M. Janssens, and J. Verhaegen. 1998. Identification of Corynebacterium amycolatum and other nonlipophilic fermentative corynebacteria of human origin. J. Clin. Microbiol. 36:1430-1432.[Abstract/Free Full Text]
  21. Willems, A., B. Pot, E. Falsen, P. Vandamme, M. Gillis, K. Kersters, and J. De Ley. 1991. Polyphasic taxonomic study of the emended genus Comamonas: relationship to Aquaspirillum aquaticum, E. Falsen group 10, and other clinical isolates. Int. J. Syst. Bacteriol. 41:427-444.[Abstract/Free Full Text]

Journal of Clinical Microbiology, March 2002, p. 1085-1087, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1085-1087.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laffineur, K.
Right arrow Articles by Delmée, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laffineur, K.
Right arrow Articles by Delmée, M.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS